Enfusion, Inc. Announces Resignation of Stephen Dorton as Chief Financial Officer, Effective January 6, 2023
November 28, 2022 at 04:10 pm
Share
Enfusion, Inc. announced that Stephen Dorton has resigned from his position as chief financial officer, effective January 6, 2023, in order to pursue another career opportunity, and not due to any disagreement with the company's operations, policies or practices. Mr. Movchan also noted that, as part of its succession planning strategy, the company maintains relationships with a number of executive search firms. He indicated that the Board of Directors had initiated discussions with several qualified CFO candidates and would conduct a search until such time as a new CFO is appointed.
Enfusion, Inc. provides software-as-a-service (SaaS) platform for investment managers. The Company, through its software, analytics, and middle/back-office managed services, creates enterprise-wide cultures of real-time, data-driven intelligence and collaboration. The Company's cloud-native, end-to-end solution gives its clients the ability to access and analyze investment information in real time, perform complex calculations and interact with markets electronically adding up to better, more informed investment decisions and actions. Its solution is highly configurable to different work streams, client segments and asset classes. The Company's solution includes portfolio management system, order and execution management system, accounting/general ledger system, Enfusion Analytics System and technology-powered, managed services. Its solution is utilized by a variety of users, including portfolio managers, traders, compliance officers, operational support staff and executive management.